Our Team
Our scientific team is composed of behavioral scientists, veterinarian, in vivo neuropharmacologists and drug development advisors whose abilities allows to take over, or to work in parallel, with your internal research teams after the first in vitro screening.
We provide a constant flow of information and data between us and our customers (time frame, updated information, scientific and contractual documents storage (acknowledgement of receipts for compounds and animals, raw data, study reports…), and discussions with the project manager.
Beside this we pay attention to ethics, animal welfare and sustainable development.
Vanessa VILLARD
PhD & MBA
Co-founder & CEO
Vanessa manages all operational and financial aspects of Amylgen.
François J. ROMAN
PhD
Co-founder & Business Development
François is working to support Amylgen to become a preferred service partner with the international biotech and pharma community.